Lundbeck CEO bags $20M bonus jumping ship for Teva helm
⇨ Lundbeck CEO Kåre Schultz landed the CEO post at Teva $TEVA, winning a $20 million signing bonus as he tackles one of the biggest reorganizations now underway in the industry. The announcement will finally lay to rest long bubbling rumors about who will helm the Israeli company.
⇨ Another senior AstraZeneca R&D exec has jumped ship. Sanjay Jariwala is moving on to Biogen, where he will be the new senior vice president, worldwide medical, reporting to Al Sandrock.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.